Researchers at Washington University School of Medicine reversed liver aging in older mice by restoring their gut bacteria to youthful compositions, according to work published in Nature Aging. The team, led by Dr. Vijay-Kumar Malathy and colleagues, transplanted preserved microbiota from the mice's own youth back into aged animals.

Older mice receiving their youthful microbiome showed dramatic improvements. Liver inflammation decreased substantially. DNA damage in liver cells reduced significantly. Most striking, the treated animals exhibited no signs of hepatocellular carcinoma, the most common form of liver cancer, while untreated controls developed tumors.

The mechanism operates through microbiota-driven gene expression. The restored young bacteria suppressed MDM2, a gene linked to cancer development and aging acceleration. This single intervention made aged livers resemble those of younger mice at the molecular level.

The researchers collected fecal samples from mice at young ages and cryopreserved the bacterial composition. When transplanted into the same mice years later, after their gut microbiomes had naturally shifted with age, the restored bacteria reversed multiple aging hallmarks.

The work builds on growing evidence that the gut microbiome influences systemic aging. Previous studies showed connections between microbiota changes and age-related diseases including neurodegeneration and metabolic dysfunction. This research directly links microbiome rejuvenation to cancer prevention in liver tissue.

However, important limitations constrain immediate clinical application. The study used laboratory mice with standardized genetics and controlled environments. Human microbiomes are vastly more complex, with hundreds more bacterial species. Individual variation in human microbial composition could alter treatment efficacy. The team has not yet tested whether the approach works when using donated young microbiota rather than patients' own preserved bacteria, a critical question for human medicine.

Additionally, the study focused on liver tissue. Benefits may not